| 摘要 |
<p>There are provided novel compounds of formula (I) wherein R ¦1?, R ¦4?, R ¦5?, G ¦1?, G ¦2?, X, L, Y ¦1?, Y ¦2? and n are as defined in the Specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of neutrophil elastase.</p> |
